Aequus Pharmaceuticals (AQSZF)

[BioSpecialist]

Great News out today ..Cannabinoid Patch =HUGE Potential

http://www.marketwired.com/press-release/aequus-licenses-rights-cannabinoid-transdermal-patch-treat-neurological-disorders-tsx-venture-aqs-2199996.htm

VANCOUVER, BC--(Marketwired - March 02, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company") announced today that through a previously announced Research Service Contract with Transdermal Research Pharma Lab ("TRPL") it has entered into a binding term sheet (the "Term Sheet") to acquire an exclusive world-wide license to a transdermal patch containing cannabinoids, for the use in epilepsy, Multiple Sclerosis (MS), and certain other neurological disorders.